Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis

Abstract The Coronavirus Disease (COVID-19) pandemic imposed a high burden of morbidity and mortality. In COVID-19, direct lung parenchymal involvement and pulmonary microcirculation dysfunction may entail pulmonary hypertension (PH). PH and direct cardiac injury beget right ventricular dysfunction...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bernadette Corica, Alberto Maria Marra, Stefania Basili, Roberto Cangemi, Antonio Cittadini, Marco Proietti, Giulio Francesco Romiti
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/37b2fb167ea0441e8584ab3737221cea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:37b2fb167ea0441e8584ab3737221cea
record_format dspace
spelling oai:doaj.org-article:37b2fb167ea0441e8584ab3737221cea2021-12-02T17:19:17ZPrevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis10.1038/s41598-021-96955-82045-2322https://doaj.org/article/37b2fb167ea0441e8584ab3737221cea2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96955-8https://doaj.org/toc/2045-2322Abstract The Coronavirus Disease (COVID-19) pandemic imposed a high burden of morbidity and mortality. In COVID-19, direct lung parenchymal involvement and pulmonary microcirculation dysfunction may entail pulmonary hypertension (PH). PH and direct cardiac injury beget right ventricular dysfunction (RVD) occurrence, which has been frequently reported in COVID-19 patients; however, the prevalence of RVD and its impact on outcomes during COVID-19 are still unclear. This study aims to evaluate the prevalence of RVD and associated outcomes in patients with COVID-19, through a Systematic Review and Meta-Analysis. MEDLINE and EMBASE were systematically searched from inception to 15th July 2021. All studies reporting either the prevalence of RVD in COVID-19 patients or all-cause death according to RVD status were included. The pooled prevalence of RVD and Odds Ratio (OR) for all-cause death according to RVD status were computed and reported. Subgroup analysis and meta-regression were also performed. Among 29 studies (3813 patients) included, pooled prevalence of RVD was 20.4% (95% CI 17.1–24.3%; 95% PI 7.8–43.9%), with a high grade of heterogeneity. No significant differences were found across geographical locations, or according to the risk of bias. Severity of COVID-19 was associated with increased prevalence of RVD at meta-regression. The presence of RVD was found associated with an increased likelihood of all-cause death (OR 3.32, 95% CI 1.94–5.70). RVD was found in 1 out of 5 COVID-19 patients, and was associated with all-cause mortality. RVD may represent one crucial marker for prognostic stratification in COVID-19; further prospective and larger are needed to investigate specific management and therapeutic approach for these patients.Bernadette CoricaAlberto Maria MarraStefania BasiliRoberto CangemiAntonio CittadiniMarco ProiettiGiulio Francesco RomitiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bernadette Corica
Alberto Maria Marra
Stefania Basili
Roberto Cangemi
Antonio Cittadini
Marco Proietti
Giulio Francesco Romiti
Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
description Abstract The Coronavirus Disease (COVID-19) pandemic imposed a high burden of morbidity and mortality. In COVID-19, direct lung parenchymal involvement and pulmonary microcirculation dysfunction may entail pulmonary hypertension (PH). PH and direct cardiac injury beget right ventricular dysfunction (RVD) occurrence, which has been frequently reported in COVID-19 patients; however, the prevalence of RVD and its impact on outcomes during COVID-19 are still unclear. This study aims to evaluate the prevalence of RVD and associated outcomes in patients with COVID-19, through a Systematic Review and Meta-Analysis. MEDLINE and EMBASE were systematically searched from inception to 15th July 2021. All studies reporting either the prevalence of RVD in COVID-19 patients or all-cause death according to RVD status were included. The pooled prevalence of RVD and Odds Ratio (OR) for all-cause death according to RVD status were computed and reported. Subgroup analysis and meta-regression were also performed. Among 29 studies (3813 patients) included, pooled prevalence of RVD was 20.4% (95% CI 17.1–24.3%; 95% PI 7.8–43.9%), with a high grade of heterogeneity. No significant differences were found across geographical locations, or according to the risk of bias. Severity of COVID-19 was associated with increased prevalence of RVD at meta-regression. The presence of RVD was found associated with an increased likelihood of all-cause death (OR 3.32, 95% CI 1.94–5.70). RVD was found in 1 out of 5 COVID-19 patients, and was associated with all-cause mortality. RVD may represent one crucial marker for prognostic stratification in COVID-19; further prospective and larger are needed to investigate specific management and therapeutic approach for these patients.
format article
author Bernadette Corica
Alberto Maria Marra
Stefania Basili
Roberto Cangemi
Antonio Cittadini
Marco Proietti
Giulio Francesco Romiti
author_facet Bernadette Corica
Alberto Maria Marra
Stefania Basili
Roberto Cangemi
Antonio Cittadini
Marco Proietti
Giulio Francesco Romiti
author_sort Bernadette Corica
title Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
title_short Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
title_full Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
title_fullStr Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
title_full_unstemmed Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis
title_sort prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with covid-19: a systematic review and meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/37b2fb167ea0441e8584ab3737221cea
work_keys_str_mv AT bernadettecorica prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT albertomariamarra prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT stefaniabasili prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT robertocangemi prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT antoniocittadini prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT marcoproietti prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
AT giuliofrancescoromiti prevalenceofrightventriculardysfunctionandimpactonallcausedeathinhospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
_version_ 1718381019763048448